Lack of Correlation between Results of ABO-Incompatible Living Kidney Transplantation and Anti-ABO Blood Type Antibody Titers under Our Current Immunosuppression
Authors:
- Hiroaki ShimmuraHSHiroaki Shimmura
- Kazunari TanabeKTKazunari Tanabe
- Hideki IshidaHIHideki Ishida
- Tadahiko TokumotoTTTadahiko Tokumoto
- Nobuo IshikawaNINobuo Ishikawa
- Naoshi MiyamotoNMNaoshi Miyamoto
- Hiroki ShirakawaHSHiroki Shirakawa
- Kiyoshi SetoguchiKSKiyoshi Setoguchi
- Ichiro NakajimaINIchiro Nakajima
- Shouhei FuchinoueSFShouhei Fuchinoue
- Satoshi TeraokaSTSatoshi Teraoka
- Hiroshi TomaHTHiroshi Toma
- 1 October 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 80 (7) , 985-988
Abstract
In this study, we examined the impact of preoperative anti-A/B antibody titers on the results of ABO-incompatible living kidney transplantation (LKT). In all, 167 recipients underwent ABO-incompatible LKT at our institution between 1989 and 2002. These patients were subdivided into those transplanted under cyclosporine with azathioprine or mizoribine (Group 1, n=78) and those transplanted under tacrolimus or mycophenolate mofetil (Group 2, n=89). Overall patient survival at 5 and 10 years was 93.8% and 88.0%, respectively. Overall graft survival at 5 and 10 years was 76.9% and 55.9%, respectively. Graft survival in the patients with anti-A/B IgG titers over 1:128 was significantly lower in group 1, whereas no significant correlation between the anti-A/B IgG titers and graft survival was found in group 2. In conclusion, no correlation between anti-A/B antibody titers and the results of ABO-incompatible LKT was seen after tacrolimus or mycophenolate mofetil application.Keywords
This publication has 12 references indexed in Scilit:
- Successful living donor renal transplantation despite ABO incompatibility and a positive crossmatchClinical Transplantation, 2004
- Excellent outcome of ABO-incompatible living kidney transplantation under pretransplantation immunosuppression with tacrolimus, mycophenolate mofetil, and steroidTransplantation Proceedings, 2004
- Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximabTransplantation, 2003
- ABO-incompatible kidney transplantation using both A2 and non-A2 living donorsTransplantation, 2003
- Mycophenolate mofetil suppresses the production of anti-blood type anitbodies after renal transplantation across the abo blood barrier: ELISA to detect humoral activity1Transplantation, 2002
- ROLE OF ANTI-A/B ANTIBODY TITERS IN RESULTS OF ABO-INCOMPATIBLE KIDNEY TRANSPLANTATION1Transplantation, 2000
- LONG-TERM RESULTS OF ABO-INCOMPATIBLE LIVING KIDNEY TRANSPLANTATIONTransplantation, 1998
- Suppression of the humoral immune response by mycophenolate mofetilNephrology Dialysis Transplantation, 1998
- TacrolimusDrugs, 1997
- Lymphocyte‐Selective Cytostatic and Immunosuppressive Effects of Mycophenolic Acid in Vitro: Role of Deoxyguanosine Nucleotide DepletionScandinavian Journal of Immunology, 1991